U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543458) titled 'Therapeutics for Moderate and Severe Dengue' on April 08.
Brief Summary: The purpose of this multi-site, factorial randomised, platform trial is to evaluate host-directed therapeutic agents in patients hospitalised with moderate and severe dengue virus infection. Our primary aim is to find safe and affordable therapeutics which prevent disease progression among those at high risk for severe dengue, and improve outcomes for those with established severe disease, thereby also reducing the substantial burden placed on health systems in dengue endemic regions.
Study Start Date: Oct. 01, 2026
Study Type: INTERVENTIONAL
Condition:
De...